| Theresa Ann Wing, | |
|
18 Mollison Way, Lewiston, ME 04240-5811 | |
| (207) 312-6860 | |
| Not Available |
| Full Name | Theresa Ann Wing |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 18 Mollison Way, Lewiston, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043887375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | RN45167 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Ann Wing, Po Box 182, Lisbon Falls, ME 04252-0182 Ph: (207) 754-0411 | Theresa Ann Wing, 18 Mollison Way, Lewiston, ME 04240-5811 Ph: (207) 312-6860 |
News Archive
With spring baseball season underway, Eric Makhni, M.D., a Henry Ford Health System sports medicine orthopedic surgeon, warns about how overuse can contribute to the high rate of arm injuries among youth players.
MS Awareness Week March 8-14 is the time for the nation to go orange and move it to end multiple sclerosis, a disease where someone is newly diagnosed every hour of every day. Supported by a Congressional resolution, this year MS Awareness Week and the state of MS research aptly coincide. Move it to create a world free of MS!
Molecular diagnostics company GenturaDx announces the completion of external HSV 1&2 alpha studies for its IDbox instrument and cassette-based tests. Conducted at an external CLIA laboratory, the study analyzed more than 130 samples, including more than 70 clinical specimens.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
› Verified 5 days ago
Darlene M Dumont, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 14 Hamel St, Lewiston, ME 04240 Phone: 207-777-8508 Fax: 207-777-4168 | |
Shauna Lane, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Strawberry Ave, Lewiston, ME 04240 Phone: 207-777-7740 | |
Amanda Leigh Mackellar, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 Rejane Ave, Lewiston, ME 04240 Phone: 207-576-3629 | |
Ms. Lori B Jacques, RN, CCM Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 93 Campus Avenue, Case Management Department, Lewiston, ME 04240 Phone: 207-777-8507 Fax: 207-753-5488 | |
Elsa Marie Heros, CNM Registered Nurse Medicare: Medicare Enrolled Practice Location: 330 Sabattus Street, Lewiston, ME 04240 Phone: 207-777-4300 Fax: 207-755-3021 | |
Addie Mckenzie, CPNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 33 Mollison Way, Lewiston, ME 04240 Phone: 207-784-5782 |